Figure 10.
Molecular docking of target genes with active ingredients of RSYRD. (A) Ferulic acid docking RB1. (B) Curcumin docking RB1. (C) Quercetin docking RB1. (D) Oleic acid docking RB1. (E) Acteoside docking RB1. (F) Curcumin docking NOS3. (G) Quercetin docking NOS3. (H) Isorhamnetin docking NOS3. (I) Benzoic acid docking NOS3. (J) Oleic acid docking NOS3. (K) Chlorogenic acid docking NOS3. (L) Ginsenoside Re docking NOS3. (M) Quercetin docking SLC16A1. (N) Benzoic acid docking SLC16A1. (O) Naringenin docking SLC16A1. (P) Pyruvic acid docking SLC16A1. (Q) Quercetin docking GAA. (R) Rutin docking GAA. (S) Isoquercitrin docking GAA. (T) (−)-Epicatechin docking GAA.
